A Comparison of Pediatric- and Adult-Onset Aquaporin-4 Immunoglobulin G–Positive Neuromyelitis Optica Spectrum Disorder: A Review of Clinical and Radiographic Characteristics. (August 2022)

• Record Type: Journal Article
• Authors: Tarhan, Bedirhan; Rempe, Torge; Rahman, Sydur; Rodriguez, Elsa; Sladky, John; Tuna, Ibrahim Sacit; Rees, John
• Is Part Of: Journal of child neurology. Volume 37:Number 8/9(2022)
• Page Start: 727
• Page End: 737
• Publication Date: 2022-08
• Subjects: MRI -- neuroimmunology -- pediatric -- autoimmune -- children -- neuroimaging -- neuroradiology -- neuroophthalmology -- outcome; Nervous system -- Diseases -- Periodicals; 618.928
• DOI: 10.1177/08830738221103085
• Languages: English
• ISSNs: 0883-0738

Abstract

Background: The identification of immunoglobulin G antibodies against the aquaporin-4 channel (AQP-IgG) in the majority of adult patients differentiates neuromyelitis optica as a distinct disease entity. The high specificity of AQP4-IgG for neuromyelitis optica has allowed the identification of seropositive patients with atypical presentations of this disease. Neuromyelitis optica spectrum disorder has been increasingly recognized in children who demonstrate patterns of clinical involvement beyond the traditional boundaries of the optic pathways and spinal cord. Methods: This is a single-center, retrospective review comparing demographic, clinical/paraclinical, and laboratory features of children and adults with a serologically confirmed diagnosis of AQP4-IgG-positive neuromyelitis optica spectrum disorder. Results: Of 151 reviewed patient charts, 12 pediatric-onset and 31 adult-onset patients had AQP4-IgG-positive neuromyelitis optica spectrum disorder. The mean age of pediatric-onset neuromyelitis optica spectrum disorder was 12 ± 3.58 years with a female predilection (3:1). Pediatric patients showed more frequent involvement of the brainstem (6/12 [50%]); P = .008) and diencephalon (3/12 [25%]; P = .018). A preceding infection was identifiable in only 3 of 12 (25%) pediatric-onset patients. Moreover, disability as calculated on the expanded disability status scale was less severe in pediatric-onset cases compared to adult-onset cases in their most recent assessment (0 [0-9]) vs 6.5 [0-10]; P = .005). Pediatric-onset patients were also more likely to respond to treatment of acute episodes with corticosteroids ± intravenous immunoglobulin and/or plasmapheresis (Clinical Global Impression–Change scale: 2.5 [1-4] vs 4 [1-6], P = .009). Interpretation: This retrospective study was able to compare and contrast pediatric- and adult-onset neuromyelitis optica spectrum disorder. Relative to their adult counterparts, pediatric-onset neuromyelitis optica spectrum disorder patients were more likely to respond to treatment and less likely to be disabled from their disease at follow-up. Therefore, pediatric-onset disease may represent a less virulent form of neuromyelitis optica spectrum disorder.